ANXA3 Polyclonal Antibody from ProteoGenix; catalogue PTX18471; research use only.
Know who made it. See the evidence. Buy through one marketplace.
ANXA3 Polyclonal Antibody is a ProteoGenix primary antibody supplied under catalogue number PTX18471 for research use only.
Target: ANXA3; Host: Rabbit; Clonality: Polyclonal Antibody; Reactivity: Anti-Human Polyclonal Antibody, Human; Applications: ELISA, WB, IHC.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Species | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| Anti-Human Polyclonal Antibody | |||||||||
| Human |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
Annexin A3 (ANXA3) is a calcium- and phospholipid-binding annexin family protein associated with membrane biology and phospholipid-dependent enzymatic regulation.
Biological function: Reviewed UniProt P12429 describes ANXA3 as an inhibitor of phospholipase A2 with anticoagulant properties and inositol 1,2-cyclic phosphate 2-phosphohydrolase activity. These functions place annexin A3 in calcium/phospholipid-dependent membrane and signalling biology.
